Abcam Founder Launches Grab for Votes to Block $5.7 Billion Deal
Jonathan Milner, the founder of UK life sciences company Abcam Plc, has fired the starting gun on a
1970-01-01 08:00
Corporate America Brings Its New Skinny Look to Stock Market
Wall Street is preparing for a wave of spinoffs as a slew of household-name companies moves to streamline
1970-01-01 08:00
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
1970-01-01 08:00
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
1970-01-01 08:00
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
1970-01-01 08:00